Fiocruz and Pasteur renew partnership on scientific cooperation

Brazil’s Fiocruz (Fundação Oswaldo Cruz) has renewed its partnership with the Pasteur Institute, part of French pharma major Sanofi (Euronext: SAN). The cooperation agreement was signed at the Institute's headquarters in Paris between Fiocruz president Nísia Trindade Lima and Pasteur director Stewart Cole.

The signing of the agreement updates the centennial partnership of scientific cooperation between the two traditional institutions, which is renewed once again under the management of the two new executives. Mr Cole took over the management of the Pasteur Institute in January of this year and Nísia Trindade Lima has been at the helm of Fiocruz since the beginning of 2017. Fiocruz has also participates in the Institut Pasteur International Network (RIIP) since 2009.

Among the novelties of this agreement are the inclusion of terms under which the institutions undertake to comply with international legislation and agreements related to biomedical research using human patients, including clinical research, use of data and the new Convention on Biological Diversity (CBD). Models of terms for the transfer of materials and staff reception were also included in this new version of the agreement.